<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="modify">
            <roleset id="modify.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent, cause of transformation&#x0A;" />
                    <role n="1" descr="thing changing&#x0A;" />
                    <role n="2" descr="method&#x0A;" />
                    <role n="3" descr="consequence&#x09;&#x09;&#x09;&#x09;// secondary predication //&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which being modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 some of which, some of which will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 subunits, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">subunits</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">some of which</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests factors that has the probability of modifing the the binding of either U5 or SH3.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests factors which has the probability of modifing the the binding of either U5 or SH3.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>The the binding of either U5 or SH3 can be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>The the binding of either U5 or SH3 can be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>The the binding of either U5 or SH3 has been actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>The the binding of either U5 or SH3 has been modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>The the binding of either U5 or SH3 has the ability to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>The the binding of either U5 or SH3 has the ability to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>The the binding of either U5 or SH3 has the probability of being actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>The the binding of either U5 or SH3 has the probability of being modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>The the binding of either U5 or SH3 is able to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>The the binding of either U5 or SH3 is able to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>The the binding of either U5 or SH3 is actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>The the binding of either U5 or SH3 is modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>The the binding of either U5 or SH3 is observed to be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>The the binding of either U5 or SH3 is observed to be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>The the binding of either U5 or SH3 may be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>The the binding of either U5 or SH3 may be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>The the binding of either U5 or SH3 might be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>The the binding of either U5 or SH3 might be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>The the binding of either U5 or SH3 was actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>The the binding of either U5 or SH3 was modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>The the binding of either U5 or SH3 will be actually modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>The the binding of either U5 or SH3 will be modified by factors suggested by analysis of one cDNA.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes being modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, some of which will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 HVDAC genes, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum being apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum being modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are able to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which are observed to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which can be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which can be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which have the ability to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which may be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which may be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which might have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which might have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which were apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which were modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which will be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, some of which will be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>An immunopurification approach has been used to demonstrate that human RNA Pol III is composed of 16 P.falciparum, subunits are apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 HVDAC genes that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are able to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are able to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are observed to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III are observed to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III can be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III can be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have the ability to be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III have the ability to be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III may be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III may be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III might have been apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III might have been modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III were apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III were modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III will be apparently modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>An immunopurification approach has been used to demonstrate that some of the 16 P.falciparum that composed human RNA Pol III will be modified in HeLa cells.</text>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests EnvZ that has the probability of modifing the OmpR.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests EnvZ which has the probability of modifing the OmpR.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests We that has the probability of modifing the P.falciparum.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>Analysis of one cDNA revealed an unusual splicing event involving EZH1 and a tandemly linked gene GPR2 and suggests We which has the probability of modifing the P.falciparum.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>The OmpR can be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>The OmpR can be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>The OmpR has been actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>The OmpR has been modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>The OmpR has the ability to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>The OmpR has the ability to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>The OmpR has the probability of being actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>The OmpR has the probability of being modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>The OmpR is able to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>The OmpR is able to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>The OmpR is actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>The OmpR is modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>The OmpR is observed to be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>The OmpR is observed to be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>The OmpR may be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>The OmpR may be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>The OmpR might be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>The OmpR might be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>The OmpR was actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>The OmpR was modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>The OmpR will be actually modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>The OmpR will be modified by EnvZ suggested by analysis of one cDNA.</text>
                    <arg n="0">EnvZ</arg>
                    <arg n="1">OmpR</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>The P.falciparum can be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>The P.falciparum can be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>The P.falciparum has been actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>The P.falciparum has been modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>The P.falciparum has the ability to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>The P.falciparum has the ability to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>The P.falciparum has the probability of being actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>The P.falciparum has the probability of being modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>The P.falciparum is able to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>The P.falciparum is able to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>The P.falciparum is actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>The P.falciparum is modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>The P.falciparum is observed to be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>The P.falciparum is observed to be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>The P.falciparum may be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>The P.falciparum may be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>The P.falciparum might be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>The P.falciparum might be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>The P.falciparum was actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>The P.falciparum was modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>The P.falciparum will be actually modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>The P.falciparum will be modified by We suggested by analysis of one cDNA.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
